A Multicenter, Randomized, Investigator-Blinded, Phase 2, Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis.

Trial Profile

A Multicenter, Randomized, Investigator-Blinded, Phase 2, Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 May 2013

At a glance

  • Drugs Metronidazole (Primary)
  • Indications Bacterial infections; Bacterial vaginosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 May 2013 Results presented at the 61st Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
    • 14 May 2010 Actual patient number (255) added as reported by ClinicalTrials.gov.
    • 14 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top